Cargando…

Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study

BACKGROUND: Childhood multidrug-resistant TB (MDR-TB) still affects around 25000 children every year across the globe. Though the treatment success rates for drug-resistant TB (DR-TB) in children are better than adults, children and adolescents face unique hurdles during DR-TB (MDR-TB, Pre-XDR TB an...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Mrinalini, Mathur, Taanya, Ravi, Shilpa, Meneguim, Augusto C., Iyer, Aparna, Mansoor, Homa, Kalon, Stobdan, Hossain, Farah Naz, Acharya, Shrikala, Ferlazzo, Gabriella, Isaakidis, Petros, Thakur, Harshad P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946226/
https://www.ncbi.nlm.nih.gov/pubmed/33690715
http://dx.doi.org/10.1371/journal.pone.0248408
_version_ 1783663008304594944
author Das, Mrinalini
Mathur, Taanya
Ravi, Shilpa
Meneguim, Augusto C.
Iyer, Aparna
Mansoor, Homa
Kalon, Stobdan
Hossain, Farah Naz
Acharya, Shrikala
Ferlazzo, Gabriella
Isaakidis, Petros
Thakur, Harshad P.
author_facet Das, Mrinalini
Mathur, Taanya
Ravi, Shilpa
Meneguim, Augusto C.
Iyer, Aparna
Mansoor, Homa
Kalon, Stobdan
Hossain, Farah Naz
Acharya, Shrikala
Ferlazzo, Gabriella
Isaakidis, Petros
Thakur, Harshad P.
author_sort Das, Mrinalini
collection PubMed
description BACKGROUND: Childhood multidrug-resistant TB (MDR-TB) still affects around 25000 children every year across the globe. Though the treatment success rates for drug-resistant TB (DR-TB) in children are better than adults, children and adolescents face unique hurdles during DR-TB (MDR-TB, Pre-XDR TB and XDR-TB) treatment. This study aimed to understand the patients, guardians and healthcare providers’ perspectives about DR-TB treatment journey of patients and caregivers. METHODS: This is a qualitative study involving in depth-interviews of purposively selected adolescents (n = 6), patients guardians (for children and adolescents, n = 5) and health care providers (n = 8) of Médecins Sans Frontières (MSF) clinic, Mumbai, India. In-depth face to face interviews were conducted in English or Hindi language using interview guides during September-November 2019. The interviews were audio-recorded after consent. Thematic network analysis was used to summarize textual data. ATLAS.ti (version 7) was used for analysis. RESULT: The age of adolescent patients ranged from 15–19 years and four were female. Five guardians (of three child and two adolescent patients) and eight healthcare providers (including clinicians- 2, DOT providers-2, counselors-2 and programme managers-2) were interviewed. The overarching theme of the analysis was: Challenging DR-TB treatment journey which consisted of four sub-themes: 1) physical-trauma, 2) emotional-trauma, 3) unavailable social-support and 4) non-adapted healthcare services. Difficulties in compounding of drugs were noted for children while adolescents shared experiences around disruption in social life due to disease and treatment. Most of the patients and caregivers experienced treatment fatigue and burnout during the DR-TB treatment. Participants during interviews gave recommendations to improve care. DISCUSSION: The TB programmes must consider the patient and family as one unit when designing the package of care for paediatric DR-TB. Child and adolescent friendly services (paediatric-formulations, age-specific counselling tools and regular interaction with patients and caregivers) will help minimizing burnout in patients and caregivers.
format Online
Article
Text
id pubmed-7946226
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-79462262021-03-19 Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study Das, Mrinalini Mathur, Taanya Ravi, Shilpa Meneguim, Augusto C. Iyer, Aparna Mansoor, Homa Kalon, Stobdan Hossain, Farah Naz Acharya, Shrikala Ferlazzo, Gabriella Isaakidis, Petros Thakur, Harshad P. PLoS One Research Article BACKGROUND: Childhood multidrug-resistant TB (MDR-TB) still affects around 25000 children every year across the globe. Though the treatment success rates for drug-resistant TB (DR-TB) in children are better than adults, children and adolescents face unique hurdles during DR-TB (MDR-TB, Pre-XDR TB and XDR-TB) treatment. This study aimed to understand the patients, guardians and healthcare providers’ perspectives about DR-TB treatment journey of patients and caregivers. METHODS: This is a qualitative study involving in depth-interviews of purposively selected adolescents (n = 6), patients guardians (for children and adolescents, n = 5) and health care providers (n = 8) of Médecins Sans Frontières (MSF) clinic, Mumbai, India. In-depth face to face interviews were conducted in English or Hindi language using interview guides during September-November 2019. The interviews were audio-recorded after consent. Thematic network analysis was used to summarize textual data. ATLAS.ti (version 7) was used for analysis. RESULT: The age of adolescent patients ranged from 15–19 years and four were female. Five guardians (of three child and two adolescent patients) and eight healthcare providers (including clinicians- 2, DOT providers-2, counselors-2 and programme managers-2) were interviewed. The overarching theme of the analysis was: Challenging DR-TB treatment journey which consisted of four sub-themes: 1) physical-trauma, 2) emotional-trauma, 3) unavailable social-support and 4) non-adapted healthcare services. Difficulties in compounding of drugs were noted for children while adolescents shared experiences around disruption in social life due to disease and treatment. Most of the patients and caregivers experienced treatment fatigue and burnout during the DR-TB treatment. Participants during interviews gave recommendations to improve care. DISCUSSION: The TB programmes must consider the patient and family as one unit when designing the package of care for paediatric DR-TB. Child and adolescent friendly services (paediatric-formulations, age-specific counselling tools and regular interaction with patients and caregivers) will help minimizing burnout in patients and caregivers. Public Library of Science 2021-03-10 /pmc/articles/PMC7946226/ /pubmed/33690715 http://dx.doi.org/10.1371/journal.pone.0248408 Text en © 2021 Das et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Das, Mrinalini
Mathur, Taanya
Ravi, Shilpa
Meneguim, Augusto C.
Iyer, Aparna
Mansoor, Homa
Kalon, Stobdan
Hossain, Farah Naz
Acharya, Shrikala
Ferlazzo, Gabriella
Isaakidis, Petros
Thakur, Harshad P.
Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study
title Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study
title_full Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study
title_fullStr Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study
title_full_unstemmed Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study
title_short Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study
title_sort challenging drug-resistant tb treatment journey for children, adolescents and their care-givers: a qualitative study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946226/
https://www.ncbi.nlm.nih.gov/pubmed/33690715
http://dx.doi.org/10.1371/journal.pone.0248408
work_keys_str_mv AT dasmrinalini challengingdrugresistanttbtreatmentjourneyforchildrenadolescentsandtheircaregiversaqualitativestudy
AT mathurtaanya challengingdrugresistanttbtreatmentjourneyforchildrenadolescentsandtheircaregiversaqualitativestudy
AT ravishilpa challengingdrugresistanttbtreatmentjourneyforchildrenadolescentsandtheircaregiversaqualitativestudy
AT meneguimaugustoc challengingdrugresistanttbtreatmentjourneyforchildrenadolescentsandtheircaregiversaqualitativestudy
AT iyeraparna challengingdrugresistanttbtreatmentjourneyforchildrenadolescentsandtheircaregiversaqualitativestudy
AT mansoorhoma challengingdrugresistanttbtreatmentjourneyforchildrenadolescentsandtheircaregiversaqualitativestudy
AT kalonstobdan challengingdrugresistanttbtreatmentjourneyforchildrenadolescentsandtheircaregiversaqualitativestudy
AT hossainfarahnaz challengingdrugresistanttbtreatmentjourneyforchildrenadolescentsandtheircaregiversaqualitativestudy
AT acharyashrikala challengingdrugresistanttbtreatmentjourneyforchildrenadolescentsandtheircaregiversaqualitativestudy
AT ferlazzogabriella challengingdrugresistanttbtreatmentjourneyforchildrenadolescentsandtheircaregiversaqualitativestudy
AT isaakidispetros challengingdrugresistanttbtreatmentjourneyforchildrenadolescentsandtheircaregiversaqualitativestudy
AT thakurharshadp challengingdrugresistanttbtreatmentjourneyforchildrenadolescentsandtheircaregiversaqualitativestudy